DAFNA CAPITAL MANAGEMENT LLC – Apellis Pharmaceuticals, Inc. Transaction History
DAFNA CAPITAL MANAGEMENT LLC portfolio value:
$4.50M
portfolio value
DAFNA CAPITAL MANAGEMENT LLC quarter portfolio value change:
+51.04%
quarter
Apellis Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -31.97% | -30.98K shares | 121K | $68.3 | 65.94K |
| Q2 2022 | share | Increase | +3.19% | 3K shares | -390K | $45.22 | 96.93K |
| Q1 2022 | share | Increase | 0.00% | 93.93K shares | 4.77M | $50.81 | 93.93K |
| Q3 2021 | share | Decrease | -100.00% | -12.70K shares | -803K | $32.96 | 0 |
| Q2 2021 | share | Decrease | -71.72% | -32.22K shares | -1.12M | $63.2 | 12.70K |
| Q1 2021 | share | Increase | +2.30% | 1.01K shares | -584K | $42.91 | 44.92K |
| Q4 2020 | share | Increase | +46.12% | 13.86K shares | 1.60M | $57.2 | 43.91K |
| Q3 2020 | share | Decrease | -10.43% | -3.5K shares | -189K | $30.17 | 30.05K |
| Q2 2020 | share | Decrease | -37.93% | -20.5K shares | -352K | $32.66 | 33.55K |
| Q1 2020 | share | Increase | +32.95% | 13.39K shares | 203K | $26.79 | 54.05K |
| Q4 2019 | share | Decrease | -76.06% | -129.14K shares | -2.84M | $30.62 | 40.65K |
| Q3 2019 | share | Increase | 0.00% | 169.8K shares | 4.09M | $24.09 | 169.8K |